Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Coherus BioSciences, Inc. | Chief Commercial Officer | Common Stock | 89.2K | $144K | $1.61 | Dec 13, 2024 | Direct |
Coherus BioSciences, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 40K | Jul 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CHRS | Coherus BioSciences, Inc. | Dec 13, 2024 | 1 | -$3.34K | 4 | Dec 17, 2024 | Chief Commercial Officer |
CHRS | Coherus BioSciences, Inc. | Jul 22, 2024 | 1 | $0 | 4 | Jul 24, 2024 | Chief Commercial Officer |
CHRS | Coherus BioSciences, Inc. | Jan 20, 2024 | 1 | -$11.8K | 4 | Jan 23, 2024 | Chief Commercial Officer |
CHRS | Coherus BioSciences, Inc. | Jan 4, 2024 | 1 | -$6.64K | 4 | Jan 8, 2024 | Chief Commercial Officer |
CHRS | Coherus BioSciences, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Chief Commercial Officer |
CHRS | Coherus BioSciences, Inc. | Dec 13, 2023 | 1 | -$4.86K | 4 | Dec 15, 2023 | Chief Commercial Officer |
CHRS | Coherus BioSciences, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Chief Commercial Officer |
CHRS | Coherus BioSciences, Inc. | Apr 1, 2023 | 1 | -$16.8K | 4 | Apr 4, 2023 | Chief Commercial Officer |
CHRS | Coherus BioSciences, Inc. | Mar 20, 2023 | 0 | $0 | 3 | Mar 28, 2023 | Chief Commercial Officer |